Schott Pharma AG & CO KGaA (1SXP)
TG
The current 1SXP market cap is 4.65B. The company's latest EPS is EUR 1.0081 and P/E is 29.80.
Year End September 29 2023 | 2023 |
---|---|
EUR (€) | |
Total Revenue | 898.6M |
Operating Income | 189.28M |
Net Income | 151.84M |
Year End September 29 2023 | 2023 |
---|---|
EUR (€) | |
Total Assets | 1.23B |
Total Liabilities | 539.65M |
Total Equity | 692.18M |
Year End September 29 2023 | 2023 |
---|---|
EUR (€) | |
Operating | 181.65M |
Investing | -171.41M |
Financing | -11.4M |
Market Cap | 4.65B |
Price to Earnings Ratio | 29.80 |
Price to Sales Ratio | 5.04 |
Price to Cash Ratio | 185.78 |
Price to Book Ratio | 6.54 |
Dividend Yield | 0.49% |
Shares Outstanding | 150.62M |
Average Volume (1 week) | 3.86k |
Average Volume (1 Month) | 2.81k |
52 Week Change | -3.13% |
52 Week High | 43.20 |
52 Week Low | 25.80 |
Spread (Intraday) | 0.14 (0.45%) |
Company Name | Schott Pharma AG & CO KGaA |
Address |
hattenbergstrasse 10 mainz 55122 |
Website | https://www.schott-pharma.com |
Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.